Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-336 As an Adjunct to Diet and Exercise in Obese Individuals with Osteoarthritis of the Knee

NCT06833749 is registered in ClinicalTrials.gov with KeyBioscience AG as lead sponsor.

NCT NCT06833749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06833749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-336 As an Adjunct to Diet and Exercise in Obese Individuals with Osteoarthritis of the Knee
Lead sponsor
KeyBioscience AG
Phase
Phase 2
Overall status
Recruiting
Start date
January 28, 2025
Completion date
December 31, 2026
Enrollment
600 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, osteoarthritis in the knee